Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 03-2012 | 02-2012 | 12-2011 | 11-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12 | N/A | 12 | N/A | N/A |
| Other current assets | 0 | 7 | 0 | 0 | 0 |
| TOTAL | $22 | $7 | $19 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 6 | N/A | 7 | N/A | N/A |
| Other Non-Current Assets | 198 | 0 | 0 | 0 | 0 |
| TOTAL | $204 | $N/A | $7 | $N/A | $N/A |
| Total Assets | $226 | $7 | $26 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 75 | 0 | 116 | 0 | 0 |
| Accrued Expenses | 16 | N/A | 16 | N/A | N/A |
| TOTAL | $113 | $N/A | $141 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 5 | N/A | 7 | N/A | N/A |
| Other Non-Current Liabilities | 1,937 | 0 | 2,206 | 0 | 0 |
| TOTAL | $1,942 | $N/A | $2,213 | $N/A | $N/A |
| Total Liabilities | $2,055 | $N/A | $2,354 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,440 | N/A | N/A | N/A | N/A |
| Common Shares | -148 | N/A | 57 | N/A | N/A |
| Retained earnings | -16,780 | N/A | -16,371 | N/A | N/A |
| Other shareholders' equity | -60 | 0 | -291 | 0 | 0 |
| TOTAL | $-1,829 | $N/A | $-2,328 | $N/A | $N/A |
| Total Liabilities And Equity | $226 | $0 | $26 | $0 | $0 |